Kai Stühler

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 8

Top Venues

Molecular medicine (Cambridge, Mass.)

PloS one

Molecular oncology

Proteomics

Heinrich-Heine-Universität Düsseldorf

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Heinrich-Heine-Universität Düsseldorf Apr 01 2011

Germany

Professor :: Proteome Research

Publications

Margaretha A Skowron, Mara Kotthoff, Felix Bremmer, Katja Ruhnke, Fatma Parmaksiz, Annika Richter, Stefan Küffer, Kirsten Reuter-Jessen, Stella Pauls, Anja Stefanski, Philipp Ströbel, Kai Stühler, Daniel Nettersheim
Targeting CLDN6 in germ cell tumors by an antibody-drug-conjugate and studying therapy resistance of yolk-sac tumors to identify and screen specific therapeutic options. Molecular medicine (Cambridge, Mass.) 29 (1) (2023)
Melissa Lubeck, Nick H Derkum, Ritam Naha, Rebecca Strohm, Marc D Driessen, Bengt-Frederik Belgardt, Michael Roden, Kai Stühler, Ruchika Anand, Andreas S Reichert, Arun Kumar Kondadi
MIC26 and MIC27 are bona fide subunits of the MICOS complex in mitochondria and do not exist as glycosylated apolipoproteins. PloS one 18 (6) (2023)
Margaretha A Skowron, Mara Kotthoff, Felix Bremmer, Katja Ruhnke, Fatma Parmaksiz, Annika Richter, Stefan Küffer, Kirsten Reuter-Jessen, Stella Pauls, Anja Stefanski, Philipp Ströbel, Kai Stühler, Daniel Nettersheim
Targeting CLDN6 in germ cell tumors by an antibody-drug-conjugate and studying therapy resistance of yolk-sac tumors to identify and screen specific therapeutic options. Molecular medicine (Cambridge, Mass.) 29 (1) (2023)
Margaretha A Skowron, Mara Kotthoff, Felix Bremmer, Katja Ruhnke, Fatma Parmaksiz, Annika Richter, Stefan Küffer, Kirsten Reuter-Jessen, Stella Pauls, Anja Stefanski, Philipp Ströbel, Kai Stühler, Daniel Nettersheim
Targeting CLDN6 in germ cell tumors by an antibody-drug-conjugate and studying therapy resistance of yolk-sac tumors to identify and screen specific therapeutic options. Molecular medicine (Cambridge, Mass.) 29 (1) (2023)
Raphael Josef Eberle, Mônika Aparecida Coronado, Ian Gering, Simon Sommerhage, Karolina Korostov, Anja Stefanski, Kai Stühler, Victoria Kraemer-Schulien, Lara Blömeke, Oliver Bannach, Dieter Willbold
Tau protein aggregation associated with SARS-CoV-2 main protease. PloS one 18 (8) (2023)
Margaretha A Skowron, Katharina Eul, Alexa Stephan, Gillian F Ludwig, Gamal A Wakileh, Arthur Bister, Christian Söhngen, Katharina Raba, Patrick Petzsch, Gereon Poschmann, Edmund Osei Kuffour, Daniel Degrandi, Shafaqat Ali, Constanze Wiek, Helmut Hanenberg, Carsten Münk, Kai Stühler, Karl Köhrer, Elvira Mass, Daniel Nettersheim
Profiling the 3D interaction between germ cell tumors and microenvironmental cells at the transcriptome and secretome level. Molecular oncology 16 (17) (2022)
Margaretha A Skowron, Teresa K Becker, Lukas Kurz, Sina Jostes, Felix Bremmer, Florian Fronhoffs, Kai Funke, Gamal A Wakileh, Melanie R Müller, Aaron Burmeister, Thomas Lenz, Anja Stefanski, Kai Stühler, Patrick Petzsch, Karl Köhrer, Peter Altevogt, Peter Albers, Glen Kristiansen, Hubert Schorle, Daniel Nettersheim
The signal transducer CD24 suppresses the germ cell program and promotes an ectodermal rather than mesodermal cell fate in embryonal carcinomas. Molecular oncology (2021)
Gereon Poschmann, Katrin Brenig, Thomas Lenz, Kai Stühler
Comparative Secretomics Gives Access to High Confident Secretome Data: Evaluation of Different Methods for the Determination of Bona Fide Secreted Proteins. Proteomics 21 (2) (2020)

Kai Stühler.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Kai Stühler